INSIDER · CIK 1967669
Ben Yong
Chief Med & Dev Officer at BridgeBio Oncology Therapeutics, Inc. (BBOT) · Director at Corbus Pharmaceuticals Holdings, Inc. (CRBP)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$16KSold on the market
2Companies
Oct 5, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 202616:11 | Oct 1, 2026 | BBOTBridgeBio Oncology Therapeutics, Inc. | Chief Med & Dev Officer | F · Tax | $3.94 | −1,047 | 43,529 | -2% | $4K | ||
| Sep 15, 202616:59 | Sep 14, 2026 | CRBPCorbus Pharmaceuticals Holdings, Inc. | Director | S · Sell10b5-1 | $7.84 | −2,000 | 9,383 | -18% | −$16K |